ε2ε4 carriers differed from ε3ε3 carriers in having lower SBP and plasma apoB, and nominally lower DBP, pulse pressure, but similar IHD and type 2 diabetes risk and HbA1c (Figs. 1C and 2C). Here, APOB is linked to myocardial ischemia.